| P50 | author | Bang-Gee Hsu | Q88434796 |
| P2093 | author name string | Yi-Maun Subeq | |
| | Du-An Wu | |
| | Jer-Chuan Li | |
| | Jia-Sian Hou | |
| | Hsin-Dean Chen | |
| P2860 | cites work | Natural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a Target | Q26741391 |
| | Sex differences in metabolic homeostasis, diabetes, and obesity | Q26784653 |
| | Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. | Q50775960 |
| | Low serum long-acting natriuretic peptide level correlates with metabolic syndrome in hypertensive patients: a cross-sectional study. | Q51343165 |
| | Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. | Q51467946 |
| | Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. | Q54076811 |
| | Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes | Q63470450 |
| | Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study | Q80049696 |
| | Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes | Q81108827 |
| | The relationship between adipocyte fatty acid binding protein-4, retinol binding protein-4 levels and early diabetic nephropathy in patients with type 2 diabetes | Q82988923 |
| | FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women | Q83272013 |
| | Associations of serum adipocyte fatty acid binding protein with body composition and fat distribution in nondiabetic Chinese women | Q86834753 |
| | Serum adipocyte fatty acid binding protein levels are positively associated with subclinical atherosclerosis in Chinese pre- and postmenopausal women with normal glucose tolerance | Q87585358 |
| | Metabolic syndrome and kidney disease: a systematic review and meta-analysis | Q26863240 |
| | Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis | Q28198287 |
| | Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 |
| | Serum adipocyte fatty acid-binding protein levels in patients with critical illness are associated with insulin resistance and predict mortality. | Q33752531 |
| | Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation | Q34567335 |
| | Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases | Q35042217 |
| | Positive correlation of serum adipocyte fatty acid binding protein levels with carotid-femoral pulse wave velocity in geriatric population | Q35709448 |
| | Possible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 Inhibitor | Q36001903 |
| | Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients | Q36794070 |
| | Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients | Q37022951 |
| | Nutritional risk and metabolic syndrome in Korean type 2 diabetes mellitus | Q37093221 |
| | Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease | Q37972596 |
| | Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? | Q38050907 |
| | Metabolic syndrome update | Q38665336 |
| | The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines. | Q39801352 |
| | Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. | Q42471476 |
| | Fasting serum fatty acid-binding protein 4 level positively correlates with metabolic syndrome in hemodialysis patients | Q42776335 |
| | Effect of metabolic syndrome and of its individual components on renal function of patients with type 2 diabetes mellitus. | Q43022798 |
| | Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease | Q43222460 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | fatty acid | Q61476 |
| | adipocyte | Q357519 |
| | metabolic syndrome | Q657193 |
| | type 2 diabetes | Q3025883 |
| P304 | page(s) | 8380279 | |
| P577 | publication date | 2016-11-29 | |
| P1433 | published in | Journal of Diabetes Research | Q26841822 |
| P1476 | title | High Serum Adipocyte Fatty Acid Binding Protein Is Associated with Metabolic Syndrome in Patients with Type 2 Diabetes | |
| P478 | volume | 2016 | |